(Q34734539)

4 August 2017

1 reference

title

Telomerase as a diagnostic and therapeutic target for cancer (English)

1 reference

4 August 2017

L Austin Doyle

1

1 reference

4 August 2017

W Edward Highsmith

series ordinal

2

1 reference

4 August 2017

publication date

1 April 2002

1 reference

Expert Review of Anticancer Therapy

4 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

4 August 2017

volume

2

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

217-225

1 reference

Telomerase catalytic subunit homologs from fission yeast and human

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Inhibition of telomerase limits the growth of human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Agents that target telomerase and telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Telomerase activity in human gynaecological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Telomerase activity in human brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Correlation of telomerase activity with development and progression of adult T-cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Detection of circulating carcinoma cells by telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

The RNA component of human telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Inhibition of human telomerase activity by peptide nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Functional requirement of p23 and Hsp90 in telomerase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

The DNA structures at the ends of eukaryotic chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Inhibition of telomerase by G-quartet DNA structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Cytotoxic T cell immunity against telomerase reverse transcriptase in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Preclinical and clinical strategies for development of telomerase and telomere inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Telomerase activity in lung cancer cells obtained from bronchial washings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

Development of Retinoblastoma in the Absence of Telomerase Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.2.217

21 January 2018

Identifiers

DOI

10.1586/14737140.2.2.217

1 reference

4 August 2017

1 reference